ALS-Con-201 practice question 25 of 25
Choose 1 option. Cumulus Pharma discovered a gap in the current call-detailing process. While field sales reps are successfully capturing consent for…
Choose your answer, then check it against the explanation.
Choose 1 option.
Cumulus Pharma discovered a gap in the current call-detailing process. While field sales reps are
successfully capturing consent for the “Immunexis KOL Webinar Series,” some records are submitted
without a digital signature. To satisfy strict audit requirements, the company mandates that every
consent captured on a mobile device must include a captured signature from the Healthcare Provider
(HCP). This requirement must be enforced globally within the Agentforce Life Sciences mobile app,
ensuring the signature pad is mandatory during the consent flow.
Which step in the Admin Console should the Agentforce Life Sciences Consultant configure?
Question 25 of 25
Keep practicing
Take the free ALS-Con-201 practice test
Ten exam-style questions with answers and explanations, plus the exam facts and study guides.
More questions
Other ALS-Con-201 practice questions
- Question 1Choose 1 option. Cumulus Pharma uses Agentforce Life Sciences for Customer Engagement to …
- Question 2Choose 1 option. Cumulus Pharma requires that sample inventory records, such as transfers…
- Question 3Choose 1 option. Field sales reps want to use the Next Best Customer feature to prioritiz…
- Question 4Choose 1 option. Cumulus Pharma is implementing a feature where Healthcare Providers (HCP…
- Question 5Choose 1 option. Cumulus Pharma uses the Territory Management feature to align Healthcare…
- Question 6Choose 1 option. Field sales reps want to use the Remote Engagement feature to facilitate…
